Episode
Oxitec’s Mosquitoes and the Promise of Malaria Control
- Podcast
- Paul Talks Science
- Published
- Jun 30, 2025
- Duration seconds
- 2135
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/paul-talks-science-7078474/episodes/oxitec-s-mosquitoes-and-the-promise-of-malaria-control/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/paul-talks-science-7078474/oxitec-s-mosquitoes-and-the-promise-of-malaria-control.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, Paul spotlights Oxitec — the biotech company behind one of the most ambitious malaria control projects on the African continent. CEO Grey Frandsen joins Paul Talks Science to break down how Oxitec’s genetically modified mosquitoes are being deployed in Djibouti to target Anopheles stephensi , an invasive urban mosquito driving malaria resurgence in cities. They discuss how the technology works, why Djibouti is leading the way, and what it takes to scale lab-bred solutions into real-world impact. It's a story of science, strategy — and the promise of fighting malaria with mosquitoes. 🧬 For the full story, read Paul’s feature in Nature Medicine : Battle of the Mosquitoes